Too much weight on too few stocks? Gurmeet Chadha suggests broader metrics for index composition
As Indian equity markets continue to evolve, some believe it's time to revisit the methodology behind index composition, particularly in ...
Tag: Weight
FDA approves first-ever glucose monitoring system for weight loss from Signos
Woman with Signos wearable and appSource: SignosThe Food and Drug Administration on Wednesday approved the first-ever glucose monitoring system specifically ...
Eli Lilly reports positive results from new weight loss pill
Eli Lilly reports positive results from new weight loss pill - CBS News
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025.Shelby Knowles | Bloomberg | Getty ImagesFor well ...
Eternal may see outflows worth $840 million following FTSE, MSCI’s weight cuts
Food delivery company Eternal, formerly known as Zomato, is staring at a passive outflow of $840 million as global index ...
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty ImagesOnly ...
Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down
People using weight loss drugs like Ozempic and Wegovy drink less People using weight loss drugs like Ozempic and Wegovy ...
Eli Lilly’s new weight loss drug is “transformational,” obesity doctor says
Eli Lilly's new weight loss drug is "transformational," obesity doctor says - CBS News
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 18%
The "Wegovy" brand slimming syringe is sold in the Achat pharmacy in Mitte. The "Wegovy" slimming syringe has been available ...
Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs
Hims & Hers Health shares plunged 18% in extended trading on Monday after investors looked past better-than-expected revenue and earnings ...
